The present work was initiated in an effort to evaluate the potential therapeutic contribution of the infusion of MSC for the correction of liver injuries.
INTRODUCTION
Mesenchymal stem cells (MSC) are described as multipotent progenitor cells that differentiate into osteocytes, chondrocytes, adipocytes, and stromal cells [1] [2] [3] . MSC have been successfully used in therapeutics [4, 5] to correct ostegenesis imperfecta [6] , to improve hematopoiesis [7] [8] [9] and to prevent Graft Versus Host Disease post hemopoietic stem cell transplantation [10] [11] [12] .
In addition to these therapeutical domains, MSC have recently received attention for their potential as regenerative medicine following radiation injuries. The ileum of irradiated pigs shows many alterations such as blunting and/or villi loss. Radiation-induced alterations of intestinal absorption have been previously described [13, 14] .
In the rat model, it has been shown that radiation induces acute alterations of the enterohepatic recirculation which concomitantly with radiation-induced intestinal malabsorption, leads to alterations of hepatic synthesis and secretion [15] . In NOD-SCID mice, intestinal radiation injury is characterized by impaired epithelial renewal, leading to mucosal disruption and functional abnormalities [16] . We have previously described the capacity of MSC to restore intestinal integrity after radiation induced damage [17] . We also have shown that MSC when infused to mice that received either extended or localized irradiation, migrate to almost all tissues where they engraft transiently usually at very low levels of detection [18] . Observations in the liver of human transplant recipients have shown a long-term implantation of a very small number of donor bone marrow cells which might be of mesenchymal origin [19] . MSC improve liver function and modulate hepatocellular death. These effects may be mediated by hepatocytes replacement and/or secretion of growth factors [20] [21] [22] .
In the present work we found that human MSC, when injected after abdominal irradiation in NOD-SCID mice, were able to indirectly preserve the liver of radiation damage. We studied the mechanism of this protection. Following our previous findings on intestinal protection, we found that the MSC regenerated the small intestine epithelium, which in turn restored the entero-hepatic recirculation pathway initially damaged by irradiation. The consequence was a distant hepatic protection without engraftment of MSC in liver.
MATERIAL AND METHODS

Culture of Human MSC
Bone marrow (BM) cells were obtained from iliac crest aspirates of healthy volunteers after informed consent and were used in accordance with the procedures approved by the human experimentation and ethic committees of the Hôpital St Antoine. As previously described. Fifty milliliters of BM were taken from different donors in the presence of heparin (Sanofi-synthélabo, France -6 M hydrocortisone (Stem Cell Technologies ® ), 2 ng/ml human basic recombinant fibroblast growth factor (R&D System, Abington, UK) in T-75 cm 2 tissue culture flasks and incubated at 37°C in humidified, 5% CO 2 atmosphere. After three days, non-adherent cells were washed with PBS and fresh medium (without hydrocortisone) was added. Samples of human MSC from different donors were collected at the second passage for transplantation.
FACS Analysis
Before injection, the MSC phenotype was checked. Stainings were performed with phycoerythrin (PE)-conjugated monoclonal antibody against CD105 (SH2), CD73 (SH3), and CD45 (Becton, Dickinson and Company, Franklin Lakes, NJ, http://www.bd.com) for 30 minutes at 4°C followed by two washes in PBS containing 0.5% BSA. Cells were re-suspended in 200 μl of PBS, 0.5% BSA, and analyzed at 10,000 events per test by FACScalibur BD (Pharmingen, San Diego,CA, USA). Mouse immunoglobulin G1 (IgG1) was used as an isotopic control (Beckman Coulter, Fullerton, CA, USA).
Irradiation
Mice were irradiated locally at the abdominal area using an ICO4000 device (Cobalt 60 source). The window of irradiation is two centimeter of width on tree centimeter of length. The dose rate is 2 Gy per minute. After anaesthesia mice were maintained on target during the time of irradiation. Each mouse was separately irradiated at the dose of 10.5 Gy.
NOD/SCID Mice Model
All experiments and procedures were performed in accordance with the French Ministry of Agriculture regulations for animal experimentation (Act n°87-847 October 19th 1987, modified May 2001) and were approved by the animal care committee of the Institut de Radioprotection et de Sûreté Nucléaire (IRSN). NOD-LtSzscid/scid (NOD-SCID) mice, from breeding pairs originally purchased from Jackson Laboratory (Bar Harbor, ME, USA) were bred in our pathogen-free unit and maintained in sterile micro isolator cages. A total of 25 twelve-week-old mice divided into 4 groups were used for this study. Two groups received IV a dose of 5.10 6 human MSC. Group 1 was a non-irradiated control group and did not receive human MSC. Group 2 was not irradiated and received MSC infusion. Group 3 was irradiated at a sub lethal dose of 10.5 Grays (Gy) and did not receive MSC infusion. Group 4 was irradiated at a sub lethal dose of 10.5 Gy and received MSC infusion 5 hours later.
PCR
The animals were sacrificed five-days after irradiation. Peripheral blood, liver and kidneys, were collected and the quantitative implantation of human MSC in mouse tissue was defined by real time PCR experiments as previously described [21] . Briefly human beta globine gene was amplified from DNA in order to detect human cell engraftment; mouse RAPSYN gene was used as control of amplification.
Histology
Liver and kidney alterations were studied by histological analysis on day five. Formalin-fixed, paraffin-embedded liver and kidney from NOD/SCID mice were cut at 5 μm on a rotary microtome (Leica Microsystems AG, Wetzlar Germany) and mounted on polysine slides. Sections were deparaffinized in xylene and rehydrated with ethanol and PBS. Sections were stained with haematoxylin, eosin and safran (HES).
Tunnel Assay
Apoptotic cells were determined using the in situ cell Death Detection kit from Roche Diagnostics (Mannheim, Germany) following the manufacturer's instructions. The apoptotic cells (brown staining) were counted under a microscope. The apoptotic index was defined by the percentage of brown (dark) cells among the total number of cells in each sample. Five fields with 100 cells per field were randomly counted for each sample. We counted a minimum of three samples, thus making a total of fifteen single analyses.
Plasma Analysis
Animals were anesthetized by Rompan-Imalgene solution and killed by intracardiac puncture with a 1-ml insulin syringe to collect blood. The abdomen was opened and the liver and kidney were rapidly excised, weighed and apportioned for preparing cellular fractions or storage at 80 °C for future use. Blood was collected in 1.5 ml tubes with heparin syringe to prevent serum formation by in vitro coagulation. Samples were centrifuged at 8000 rpm at 4 °C for 5 min to collect the plasma. We used an automated Konelab 20 apparatus (Thermo Electron Corporation, Courtaboeuf, France) system to measure plasma alanine amino-transferase (ALT), aspartate amino-transferase (AST), (biological chemistry reagents, Bayer Diagnostics) in the control and different groups of mice.
Quantification of Liver Bilic Acids
Liver samples were previously homogenised in 150 mM NaCl. The procedure of sample extraction is adapted from Keller and al. Nor-cholic acid was used as the internal standard. Analysis of bilic acids (BA) was performed by Gas Chromatography-Mass Spectrometry (GC-MS).
Statistical Analysis
All values were expressed as the mean and SEM (Standard Error of the Mean). To compare results between groups, we used a T test or a one-way ANOVA followed by Tukey test with Sigmastat software (Systat Software Incorporation). Significance for all analyses was set at ***P<0.001 or **P<0.05.
RESULTS
MSC Characterisation
Phenotypic analysis showed that the MSC used in these experiments following expansion, were strongly positive for the specific surface antigens SH2 and SH3, respectively 37.3% ± 4.0 and 72.9% ± 3.7. Almost no contamination (0.2% ± 0.1 CD 45+ cells) by haematopoietic cells was detected ( Table 1) . MSC had their specific fibroblast-like appearance. Before use, we checked that each batch of MSC retained its specific ability to undergo osteogenic, chondrogenic and adipogenic differentiation. Our results suggest that the MSC used in these experiments for transplant were expanded without significant loss in their differentiation capacities.
MSC were not Found in Liver
Human MSC were tracked in liver and gut at five-days after injection using real time PCR. MSC engrafted is small intestine (0.2% ± 0.03) but not in liver.
MSC have no Hepatotoxic Potential
There was no significant variation in ALT (108 ± 18.9 U/I) and AST (20.3 ± 0.8 U/I) levels when we compared control mice with mice receiving MSC (ALT= 113 ± 43.5 U/I, AST=17.4 ± 1.7 U/I). (Fig. 1a and 1b) .
Irradiation has A Hepatotoxic Effect
Abdominal irradiation resulted in a significant elevation of the ALT (353.9 ± 37.5 U/I vs. 108.6 ± 18.9 U/I) and AST (40.3 ± 4.9 U/I vs. 20.3 ± 0.8 U/I) levels after five-days (p<0.001) (Fig. 2a and 2b) . Therefore, hepatic function was altered five-days after abdominal irradiation. By TUNEL marking on the liver before and after irradiation, we observed that irradiation induced apoptosis of the endothelial cells and the cells lining the bile ducts which are polarised hepatocytes. Irradiation induced damage to the liver (Fig. 3a. and 3b) . Fig. (1) . Absence of toxicity of human MSC infused to NOD/SCID mice. Hatched histograms correspond to control animals non irradiated receiving no MSC ( n=7). White histograms correspond to non irradiated animals receiving MSC (n=4). There was no difference between the two groups for plasma levels of transaminases AST (a) and ALT (b).
MSC Protect the Liver After Irradiation
MSC infusion prevented AST (198.8 ± 43.1 U/I) and ALT (14.9 ± 4.7 U/I) from increasing five-days after irradiation (p<0.05 and p<0.01 respectively). (Fig. 2a and 2b) .
MSC Injection Limits Liver Apoptosis (Figure 3c)
Five-days after irradiation, apoptosis was investigated in the liver. In the untreated group irradiation induced apoptosis in the endothelial layer of vessels was observed (29% ± 7 of apoptotic cells). However, when mice were transplanted with MSC the apoptotic areas disappeared (3% ± 2 apoptotic cells, P<0.001 compared to untreated group, Table 2 ).
MSC Protect the Entero-Hepatic Recirculation Pathway
Intestinal malabsorption is associated with an alteration of the enterohepatic recirculation of bile acids. In Fig. (4) we only present the variation of the most hydrophobic acid, DCA, in so far as the others did not vary significantly. After abdominal irradiation, bile acid concentrations were disturbed. The results show that DCA concentration increased approximately 2-fold. In contrast, after MSC injection the concentration of DCA equalled the control level. MSC therefore can prevent a five-days increase in deoxycholic acid concentration. MSC can correct the radioinduced disturbances which cause the variation of DCA. Since bile acids are regulated by the bowel, MSC can restore intestinal absorption of DCA.
DISCUSSION
The present work was initiated in an effort to evaluate the potential therapeutic contribution of the infusion of MSC for the correction of liver injuries induced by an irradiation exposure.
Fig. (2). Effect of irradiation and MSC infusion on liver.
Hatched histograms correspond to non irradiated control animals receiving no MSC (n=7). Grey histograms correspond to irradiated animals (dose: 10.5 Gy) with no MSC infusion (n=5). Black histograms correspond to animals receiving MSC after irradiation (n=8). Plasma dosages were done on day 5 post irradiation. (a) Transaminases AST: a significant increase in the AST plasma concentration was observed which was multiplied by 3-fold (p<0.001). MSC infusion resulted in a significant reduction of the increase (p<0.05). (b) Transaminases ALT: a significant increase in the ALT plasma concentration was observed which was multiplied by 2-fold (p<0.01). MSC infusion resulted in a significant reduction of the increase (p<0.05). Fig. (3) . Evaluation of apoptosis in the liver five-days after irradiation followed or not by MSC infusion. TUNEL staining: apoptotic and necrotic cells appear brown-coloured (red arrows). (A) Control, the necrotic and apoptotic cells seen after irradiation alone (B) were not seen in animals receiving MSC (C) post irradiation (Magnification x10). Fig. (4) . Deoxycholic acid (DCA) variation five-days after irradiation followed or not by MSC infusion. Hatched histograms correspond to non irradiated control animals (n=7), grey histograms to irradiated animals, black histograms to animals receiving MSC after irradiation (n=11). DCA concentration in liver increased significantly (p<0.01), by a factor of 2, five-days after irradiation. After infusion of MSC, DCA concentration did not increase. The significant result for irradiated versus irradiated and treated is p<0.01.
We subjected NOD-SCID mice to a 10. 5 Gy abdominal irradiation and we tested the biological and histological markers of liver injury in the absence and after infusion of expanded human MSC. Irradiation alone induced a significant elevation of the ALT and AST. Necrosed endothelial cells and the cells lining the bile ducts were observed. Infusion of MSC into animals five hours after irradiation induced a significant decrease of transaminases, and an almost total disappearance of apoptotic cells. An effect of MSC with a decrease of apoptosis has however been described in a different situation, namely acute renal failure (ARF) [23] .
To explain the restoration of liver damage as evaluated by the correction of transaminase levels and the decreasing number of apoptotic cells in the liver, as well as the absence of detectable implantation of MSC in the liver at five-days after infusion, we hypothesize an indirect action on the liver via the intestinal tract. Total body irradiation and abdominal irradiation induce structural and functional gut damage [23] , [16, 24] with a decrease of villi height [17] and malabsorption [15] . Intestinal malabsorption in turn induces an alteration of the enterohepatic recirculation of bile acids [15] , with an increase in Deoxy Cholic Acid (DCA) which is described as one of the most cytotoxic of them [25] . Indeed, in the present study, DCA concentration increased approximately 2-fold after irradiation but went back to the baseline level after MSC. We propose that, following irradiation, MSC infusion indirectly corrected liver dysfunction by preventing gut damage. One mechanism for this indirect effect is the alteration of the entero-hepatic recirculation pathway. Another mechanism that should be considered is the role of cytokines and growth factors produced by the MSC that are homing to other organs. Recent publications by VanPoll et al. (Hepatology 2008) showed in a model of fulminant hepatic failure (FHF) suggest that the infusion of conditioned medium from MSC protects from apoptosis in the liver and stimulate hepatocyte proliferation [20] . The indirect effect of MSC on the liver reported in the present study could correspond to a similar mechanism.This explanation would be consistent with the absence of detection of MSC in the liver. We believe our observation brings an additional piece of evidence in favour of the use of MSC in patients submitted to pelvic or total body irradiation.
